مجلس نيوز | majlis-news
Pfizer and Biontec announced, in a statement today (Thursday), that their vaccine against Covid-19 preserves the bulk of its effectiveness against the two major mutations of the emerging corona virus in Britain and South Africa.
The statement stressed, according to “the French News Agency” that the tests did not indicate the need for a new vaccine to deal with the emerging variables.
He explained that the coalition continues to monitor emerging variants and is ready to respond if one of these mutations is resistant to the vaccine.